To cite this paper use one of the standards below:
Bovine babesiosis, a tick-borne disease, is caused by the Babesia bovis parasite. The main symptoms are fever, anemia and even death of cattle, causing a negative impact for meat and dairy producers. The drugs currently used face resistance by the parasite and serious adverse effects. In this context, dihydrofolate reductase, a key enzyme in folate metabolism, becomes an interesting target for the development of new drugs against the parasite. A comparative analysis of the active site of the parasite enzyme was carried out against species of mammals, to identify differences which could be exploited for high selectivity. A virtual screening is being carried out in a database of molecules where, at first, the pharmacophoric model is used as a filter, later, the molecules of the hit list will undergo molecular docking with the target. With this work we intend to reach new candidates for selective drugs against bovine babesiosis.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper